Home Tags The METRIC Trial

Tag: The METRIC Trial

Market Trend: Cancer Immunotherapy Destined for Growth

According to data provided by Allied Market Research, the global cancer immunotherapy market is expected to grow to $117.14 billion by 2022, growing at...

Glembatumumab Vedotin in Patients with Metastatic gpNMB-overexpressing Triple-negative Breast Cancer

Researchers have, in the last decades, made major advances in the development of therapies for breast cancer by identifying key markers known to drive...

FEATURED RESOURCES